MicroRNAs Differentially Expressed in Actinic Keratosis and Healthy Skin Scrapings

Actinic keratosis (AK) is a carcinoma in situ precursor of cutaneous squamous cell carcinoma (cSCC), the second most common cancer affecting the Caucasian population. AK is frequently present in the sun-exposed skin of the elderly population, UV radiation being the main cause of this cancer, and other risk factors contributing to AK incidence. The dysregulation of microRNAs (miRNAs) observed in different cancers leads to an improper expression of miRNA targets involved in several cellular pathways. The TaqMan Array Human MicroRNA Card assay for miRNA expression profiling was performed in pooled AK compared to healthy skin scraping samples from the same patients. Forty-three miRNAs were modulated in the AK samples. The expression of miR-19b (p < 0.05), -31, -34a (p < 0.001), -126, -146a (p < 0.01), -193b, and -222 (p < 0.05) was validated by RT-qPCR. The MirPath tool was used for MiRNA target prediction and enriched pathways. The top DIANA-mirPath pathways regulated by the targets of the 43 miRNAs are TGF-beta signaling, Proteoglycans in cancer, Pathways in cancer, and Adherens junction (7.30 × 10−10 < p < 1.84 × 10−8). Selected genes regulating the KEGG pathways, i.e., TP53, MDM2, CDKN1A, CDK6, and CCND1, were analyzed. MiRNAs modulated in AK regulate different pathways involved in tumorigenesis, indicating miRNA regulation as a critical step in keratinocyte cancer.

[1]  Xintong Han,et al.  The Role of CTNNA1 in Malignancies: An Updated Review , 2023, Journal of Cancer.

[2]  J. Shalhoub,et al.  Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017. , 2022, The British journal of dermatology.

[3]  E. Li,et al.  Role of Cell-Cell Junctions in Oesophageal Squamous Cell Carcinoma , 2022, Biomolecules.

[4]  M. Tommasino,et al.  The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs , 2022, Infectious Agents and Cancer.

[5]  M. Tommasino,et al.  The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs , 2022, Infectious agents and cancer.

[6]  C. Dinu,et al.  Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution? , 2021, Genes.

[7]  V. Sondak,et al.  Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas , 2021, Cancer Research.

[8]  Li Qian,et al.  Adipose mesenchymal stem cell-derived exosomes accelerate skin wound healing via the lncRNA H19/miR-19b/SOX9 axis , 2021, Laboratory Investigation.

[9]  P. Golusiński,et al.  Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients , 2021, Archives of Dermatological Research.

[10]  Yuchen Liu,et al.  Synthesis of RNA-based gene regulatory devices for redirecting cellular signaling events mediated by p53 , 2021, Theranostics.

[11]  Guanghui Liu,et al.  CDK6 is stimulated by hyperthermia and protects gastric cancer cells from hyperthermia-induced damage , 2021, Molecular medicine reports.

[12]  Rosario N. Brancaccio,et al.  Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing , 2020, Papillomavirus research.

[13]  M. Neagu,et al.  miRNAs in the Diagnosis and Prognosis of Skin Cancer , 2020, Frontiers in Cell and Developmental Biology.

[14]  M. Sohel Circulating microRNAs as biomarkers in cancer diagnosis. , 2020, Life sciences.

[15]  P. Di Bonito,et al.  Human Papillomavirus and carcinogenesis: Novel mechanisms of cell communication involving extracellular vesicles , 2020, Cytokine & Growth Factor Reviews.

[16]  Jun Zhang,et al.  miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[17]  J. Pérez-Losada,et al.  MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma , 2019, International journal of molecular sciences.

[18]  M. Tommasino HPV and skin carcinogenesis , 2019, Papillomavirus research.

[19]  M. Tommasino,et al.  Comprehensive analysis of β‐ and γ‐human papillomaviruses in actinic keratosis and apparently healthy skin of elderly patients , 2019, The British journal of dermatology.

[20]  Jing Tian,et al.  miR-186 promotes tumor growth in cutaneous squamous cell carcinoma by inhibiting apoptotic protease activating factor-1 , 2018, Experimental and therapeutic medicine.

[21]  G. Leonardi,et al.  Actinic keratosis – review for clinical practice , 2018, International journal of dermatology.

[22]  E. Olasz,et al.  The microRNA landscape of cutaneous squamous cell carcinoma. , 2018, Drug discovery today.

[23]  I. Barshack,et al.  Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes , 2018, Oncogene.

[24]  Hsuan Liu,et al.  MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2 , 2018, Theranostics.

[25]  Hongfu Zhang,et al.  MicroRNA-126 participates in lipid metabolism in mammary epithelial cells , 2017, Molecular and Cellular Endocrinology.

[26]  M. Weinstock,et al.  Current perspective on actinic keratosis: a review , 2017, The British journal of dermatology.

[27]  T. Gambichler,et al.  Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma. , 2017, Journal of dermatological science.

[28]  J. Mott,et al.  FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis , 2017, Journal of Lipid Research.

[29]  M. Weinstock,et al.  Predictors of actinic keratosis count in patients with multiple keratinocyte carcinomas: A cross‐sectional study , 2017, Journal of the American Academy of Dermatology.

[30]  J. Lapins,et al.  MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC. , 2016, The Journal of investigative dermatology.

[31]  Xiaohang Chen,et al.  miR-34a and its novel target, NLRC5, are associated with HPV16 persistence. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[32]  J. Fletcher,et al.  Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3 , 2016, Oncotarget.

[33]  Zheng Li,et al.  The role of miRNAs in cutaneous squamous cell carcinoma , 2015, Journal of cellular and molecular medicine.

[34]  G. Melino,et al.  KMT Set7/9 affects genotoxic stress response via the Mdm2 axis , 2015, Oncotarget.

[35]  Jaak Vilo,et al.  ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap , 2015, Nucleic Acids Res..

[36]  H. Kitagawa,et al.  Biosynthesis and function of chondroitin sulfate. , 2013, Biochimica et biophysica acta.

[37]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.

[38]  M. Oren,et al.  p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin , 2011, PloS one.

[39]  Lan Xu,et al.  miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.

[40]  Gui-yuan Li,et al.  Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. , 2009, Cancer research.

[41]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[42]  Zhixiang Wang ErbB Receptors and Cancer. , 2017, Methods in molecular biology.

[43]  P. ten Dijke,et al.  Targeting TGF-β Signaling in Cancer. , 2017, Trends in cancer.

[44]  Yi Wang,et al.  MicroRNA-126 attenuates palmitate-induced apoptosis by targeting TRAF7 in HUVECs , 2014, Molecular and Cellular Biochemistry.